Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Recalls Soared Again in 2013, Driven by Contamination

May 30 2014

• By Bowman Cox

Related Content

Glass Quality Crisis Prompts Multi-Faceted Array of Risk-Based Improvements

Aug 01 2011

What FDA Saw at Compounder Behind Fungal Meningitis Outbreak

Nov 29 2012

Contamination Issues Drove Drug Recalls to Record Levels in 2011

Mar 28 2012

Contamination and Raw Material Testing Issues Raised in FDA Warning Letters

Sep 27 2013

Contamination, Mix-Ups Drive Up Drug Recall Totals for 2012

May 30 2013

Related Companies

Amgen, Inc.

Hikma Pharmaceuticals plc

Hikma Pharmaceuticals plc

Strides Pharma Science Limited

Novartis AG

ASCEND Therapeutics, LLC

Warner Chilcott PLC

Bausch Health Companies Inc.

Genentech, Inc.

Pacira BioSciences, Inc.

Church & Dwight Co. Inc.

Bayer AG

Boehringer Ingelheim GmbH

Viatris Inc.

Apotex Inc.

Hospira, Inc.

AstraZeneca PLC

ACS Dobfar SPA

Fresenius SE & Co. KGaA

Gilead Sciences, Inc.

Astellas Pharma, Inc.

Zydus Pharmaceuticals (USA) Inc.

Cadila Pharmaceuticals Ltd.

Cardinal Health, Inc.

Novartis AG

Endo, Inc.

Viatris Inc.

Pfizer Inc.

Greenstone Healthcare Solutions

Additional Topics

Manufacturing Quality Recalls

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window